On Dec 23, BioLexis Pte Ltd., Director exercised an option 2,909,091 shares of Outlook Therapeutics Inc. (NASDAQ: OTLK), with the average selling price of the stock being $0.23 per share. The total amount realized from this exercised an option $674,909. A document was filed with the Securities and Exchange Commission to notify the public about the exercised an option of the shares.
The recent price movement of OTLK means that it is now down by -91.06% from its 52-week high and 88.46% up against its 52-week low prices. Over the past one week, the price volatility of OTLK stands at 7.56% while the volatility over the past one month is 15.58%. The beta score for this stock is -0.88. A beta score below 1 means that the stock has a low volatility while above 1 signifies that a stock is highly volatile at that particular moment, a data that traders use to keep tabs on their investments.
The company published its latest quarterly earnings, with the report showing that the company recorded -2.56 earnings per share (EPS) during that period. This report was below the expectations of analysts of -1.84 by -0.72. The revenue by the firm was 250k for the quarter.
The shares of Outlook Therapeutics Inc. (OTLK) gained by 13.94%, leading to a gain of $0.12 per share, and saw OTLK end the trading session at $0.98 on Thursday 01/16/20. OTLK started the trading session at $0.8783, before reaching a daily high of $1.01. It wasn’t able to sustain that growth though and soon jumped to hit a daily low of $0.8701.
The trading volume on Thursday stood at 1134693, which was below the stock’s 3-month average volume of 902.07K shares, out of a total 12.14M shares. As the price of the stock climbed, the market valuation of the company gained to 29.78 million.
The shares of PPL Corporation (NYSE: PPL) went up by 0.31% by the end of the recent trading session. This movement saw its price surge to close at $35.96, which was higher than the previous closing price of $35.85. Over the past one week, the price of PPL has jumped by 1.27%, while it has recorded a loss of -0.80% over the past one month. Its three-month performance saw PPL gain 10.95% while its six-month performance saw it surge by 17.13%. The situation is different though over the past one year, as the stock price went up by 21.16%, while its year-to-date (YTD) price performance jumped by 0.22%. The stock price has gone up by +13.22% compared to its 90-day low, while it is down -0.88% compared to its 90-day high price.
Let’s take a look at its short, medium and long-term indicators. Composite Indicators shows that Trendspotter rated the stock as a Buy. In the short-term, the stock has a 20-day average volume of 4,295,150 shares, with the short-term indicators averagely rating the stock as a 100% Buy. A look at its medium-term indicators reveals that it has a 50-Day average volume of 4,866,618 shares and the indicators have an average rating of 100% Buy. The last indicators, the long-term see PPL stock with a 100-Day average volume of 4,826,080 shares, giving it an average rating of 100% Buy. A look at the general picture of all short, medium and long-term indicators leaves PPL with an average rating of 100% Buy.
Several brokerage firms sent out their reports PPL stock not long ago. In its report sent out on January 08, 2020, Guggenheim lowered its ratings on PPL from a Neutral to a Buy. In an earlier report on October 23, 2019, Macquarie Upgrade the stock from a Underperform to a Neutral. Mizuho meanwhile in its report on June 03, 2019 Initiated its rating of the stock to “Neutral”.
In related news to the company’s stock, around 73.20% shares are being held by institutional investors. In a recent SEC filing, the company revealed that 847 institutions currently hold the PPL stock. In the last quarter, a 514,581,204 PPL shares were in the possession of institutions. On the other hand, the company recorded 62 new institutions who bought it their stock, while 50 institutions sold their entire PPL reserve. Of the current institutions investing in the stock, 391 increased their investment while 338 decreased their investment in the stock.